# Study of the Efficacy and Safety of Bupivacaine TTS Patch in Patients With Chronic Low Back Pain

> **NCT01096966** · PHASE2 · COMPLETED · sponsor: **Durect** · enrollment: 263 (actual)

## Conditions studied

- Chronic Low Back Pain

## Interventions

- **DRUG:** Bupivacaine TTS (Bupivacaine Patch)
- **DRUG:** Placebo patch

## Key facts

- **NCT ID:** NCT01096966
- **Lead sponsor:** Durect
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 263 (ACTUAL)
- **Last updated:** 2022-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01096966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01096966, "Study of the Efficacy and Safety of Bupivacaine TTS Patch in Patients With Chronic Low Back Pain". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01096966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*